Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 12 - 09 entities : Gilead sciences, inc. save search
Kite and Arcellx Announce Strategic Collaboration to Co-develop and Co-commercialize Late-stage Clinical CART-ddBCMA in Multiple Myeloma
Published: 2022-12-09 (Crawled : 16:00) - biospace.com/
ACLX | $52.795 -3.02% -3.12% 300K
|
|
| O: 20.66%
H: 9.21%
C: 7.11%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -1.45%
collaboration
Arcellx and Kite Announce Strategic Collaboration to Co-Develop and Co-Commercialize Late-Stage Clinical CART-ddBCMA in Multiple Myeloma
Published: 2022-12-09 (Crawled : 14:00) - biospace.com/
ACLX | $52.795 -3.02% -3.12% 300K
|
|
| O: 20.66%
H: 9.21%
C: 7.11%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -1.45%
collaboration
ImmunoGen Announces Clinical Collaboration with Gilead to Evaluate Pivekimab Sunirine in Combination with Magrolimab in Relapsed/Refractory Acute Myeloid Leukemia
Published: 2022-12-09 (Crawled : 13:00) - biospace.com/
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: -0.19%
H: 0.77%
C: -0.77%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -1.45%
collaboration leukemia acute myeloid leukemia
Myriad Genetics Patient Outcomes Study Shows RiskScore Leads to More Accurate Breast Cancer Risk Prediction than Standard-of-Care Risk Model Myriad Genetics, Inc., a leader in genetic testing and preci...
Published: 2022-12-09 (Crawled : 13:00) - biospace.com/
SXT | $70.03 0.2% 0.0% 1.3M
|
Distribution Services
|
| O: -0.42%
H: 0.97%
C: -0.33%
PFE | News 4 | $26.27 -0.19% -0.15% 23M
|
Health Technology
|
| O: -0.06%
H: 2.11%
C: -0.06%
TRIB | $1.83 -3.87% 11K
|
Health Technology
|
| O: -1.56%
H: 1.58%
C: -1.75%
REPL | $6.32 -1.56% -1.58% 630K
|
Health Technology
|
| O: -0.25%
H: 5.25%
C: 4.17%
MYGN | $18.61 0.05% 0.05% 480K
|
Health Technology
|
| O: -0.67%
H: 1.39%
C: -2.69%
IMGN | News | $31.23 0.03% 49M
|
Health Technology
|
| O: -0.19%
H: 0.77%
C: -0.77%
GILD | $67.07 0.06% 0.06% 8.3M
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -1.45%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.05%
H: 0.75%
C: -0.83%
APM | $5.69 3.45% 3.34% 17K
|
Health Technology
|
| O: -16.14%
H: 19.24%
C: 14.67%
risk breast genetic cancer study
Gainers vs Losers
| 65% | 35% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 210M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.